Continuous Compared With Cyclic Oral Contraceptives for the Treatment of Primary Dysmenorrhea
- 1 June 2012
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 119 (6) , 1143-1150
Abstract
OBJECTIVE: To estimate whether continuous oral contraceptive pills (OCPs) will result in more pain relief in primary dysmenorrhea patients than cyclic OCPs, which induce withdrawal bleeding with associated pain and symptoms. METHODS: We conducted a double-blind, randomized, controlled trial comparing continuous to a cyclic 21–7 OCP regimen (gestodene 0.075 mg and ethinyl estradiol 20 microgram) for 6 months in 38 primary dysmenorrhea patients. The primary outcome was the difference in subjective perception of pain as measured by the visual analog scale over a period of 6 months. RESULTS: Twenty-nine patients completed the study. In both groups, pain reduction measured by visual analog scale declined over time and was significant at 6 months compared with baseline, with no difference between groups. Continuous regimen was superior to cyclic regimen after 1 month (mean difference −27.3, 95% confidence interval [CI] −40.5 to −14.2; P<.001) and 3 months (mean difference −17.8, 95% CI −33.4 to −2.1; P=.03) of treatment. Secondary outcomes noted no difference between groups in terms of menstrual distress as measured by the Moos Menstrual Distress Questionnaire. After 6 months, there was an increase in weight and a decrease in systolic blood pressure in the continuous group compared with the cyclic group. CONCLUSION: Both regimens of OCPs are effective in the treatment of primary dysmenorrhea. Continuous OCPs outperform cyclic OCPs in the short term, but this difference is lost after 6 months. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, www.clinicaltrials.gov , NCT00517556. LEVEL OF EVIDENCE: IKeywords
This publication has 28 references indexed in Scilit:
- Use of the oral contraceptive pill is associated with increased large artery stiffness in young women: The ENIGMA StudyJournal Of Hypertension, 2011
- Oral contraceptive pill for primary dysmenorrhoeaCochrane Database of Systematic Reviews, 2009
- Effects of ContinuousVersusCyclical Oral Contraception: A Randomized Controlled TrialThe Journal of Clinical Endocrinology & Metabolism, 2008
- Oral contraceptives maintain a very thin endometrium before operative hysteroscopyFertility and Sterility, 2006
- Oral Contraceptives for Dysmenorrhea in Adolescent GirlsObstetrics & Gynecology, 2005
- Clinical and metabolic aspects of the continuous use of a contraceptive association of ethinyl estradiol (30 μg) and gestodene (75 μg)Contraception, 2004
- Vascularization of Human EndometriumAnnals of the New York Academy of Sciences, 1994
- Uterine blood flow and myometrial activity at menstruation, and the action of vasopressin and a synthetic antagonistBJOG: An International Journal of Obstetrics & Gynaecology, 1988
- Prostaglandins and the Non-Pregnant Uterus the Pathophysiology of primary dysmenorrheaActa Obstetricia et Gynecologica Scandinavica, 1983
- Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tri-cycle pill regimen.BMJ, 1977